It's Father's Day. And all dads out there deserve a pat on the back, a sincere thank you, a celebration in their honor. But there's one group of dads to whom I'm giving special attention on this fine Sunday, June 17 -- dads with cancer.

Having been a mom with cancer, I know how parenting becomes doubly difficult when a life-threatening illness crowds into the picture. The usual mommy and daddy responsibilities are hard enough on their own. Add cancer and all sense of balance, control, and even joy can fly out the window.

Holding down the daddy fort while battling and surviving cancer is no small task. So let's honor some of the dads who manage this feat. Here are seven of them.

The world's largest drug maker -- Pfizer Inc. -- announced Monday it will cut 10,000 jobs and close at least five facilities due to fierce competition from generic drug makers. The goal, says Pfizer spokespeople, is to whittle away annual costs by $2 billion by the end of the year -- to combat the prediction that the company will lose 41 percent of its sales to generic drugs between 2010 and 2012.

Pfizer's other obstacles include expiring drug patents -- costing Pfizer about $14 billion in revenues between 2005 and 2007 -- as well as demands for lower prices by insurers and large purchasers, and repeated requests for evidence of products' worth.

The 10,000 layoffs amount to 10 percent of the company's global workforce and will take jobs from 2,200 United States employees. The company will cut 20 percent of its European sales force, will close three research sites in Michigan and two manufacturing plants in New York and Nebraska, and is considering selling a manufacturing site in Germany and closing two research sites in Japan and France. In the midst of all of this, the company will focus its efforts on transforming the way they do business.

"I believe we must transform the way we've done business in the past in order to be more successful in the future," said Jeffrey Kindler, CEO and chairman of Pfizer. " Incremental evolution is not enough. Fundamental change is imperative -- and it must happen now."

Pfizer's Monday announcement is the second declaration of budget cuts. A previous announcement has the company -- the maker of cancer drugs Aromasin, Ellence, Camptosar, and Sutent -- slashing costs by $4 billion a year until 2008.

Tampa's H. Lee Moffitt Cancer Center & Research Institute, the only comprehensive cancer center in Florida, has just partnered with Merck & Co., one of the world's largest drug companies, to develop personalized cancer treatments using a patient's genetic profile.

The two powerhouse entities will form a for-profit company called M2Gen on donated land near the University of South Florida. And in the span of just a few years, researchers plan to compile a database of tumor tissue and other medical information to determine why some patients respond to treatment while others do not. The database could house information on more than 30,000 patients within five years and will enable researchers to identify biological markers that could help doctors choose the most effective treatment based on the genetic make-up of each patient's tumor.

Blind treatment -- where everyone receives the same thing -- will be a thing of the past as tailor-made therapies replace the one-size-fits-all approach.

Florida Governor Jeb Bush says of the partnership that will create more than 170 high-paying jobs, "Man, I don't know if you can think of a better Christmas present than that."

My mom's best friend died from pancreatic cancer just three months after her diagnosis with the disease. One of my co-workers lost her mother to the same disease just weeks after diagnosis. Another co-worker's husband lost his battle with pancreatic cancer after a 15-month all-out fight. And a family friend has somehow been surviving this deadly disease for years now. He's the exception, defying the odds rarely in favor of long-term survival.

About 33,730 people will be diagnosed with pancreatic cancer in 2006. Many of them -- 32,300 -- will die from the disease that is rarely caught early. Pancreatic cancer is the fifth leading cause of cancer death in the United States.

Celebrities have a way of motivating the public to take action. They help dictate fashion trends and set standards for mostly unattainable body shapes and sizes. They add hype to political views and philosophies and make influential statements about all sorts of issues. Like breast cancer. With its backing from celebrities like Melissa Etheridge and Sheryl Crow and Kylie Minogue -- all breast cancer survivors who are speaking out and raising awareness -- breast cancer has burst onto the media scene and is receiving powerful, positive attention. Kylie Minogue's public diagnosis spurred so many women into getting their breasts checked that the Medical Journal of Australia reports a 40 percent increase in bookings for mammograms. But sometimes, celebrity diagnoses don't elicit a response at all.

Italian tenor Luciano Pavarotti was diagnosed with pancreatic cancer last month -- yet the announcement barely registered on the public's radar. Perhaps he does not command the same kind of reaction as pop singers do. Or perhaps it's the type of cancer that keeps his public battle on the sidelines.

The breasts are a visible icon of femininity -- out in the forefront for all to see. And so the issue of breast cancer is in the forefront. The pancreas, on the other hand, are hidden behind the stomach and are out of sight -- and out of mind. When Apple chief executive Steve Jobs was diagnosed with pancreatic cancer in 2004, he didn't even know where to find his pancreas. And so this organ does not attract much fanfare -- and therefore does not attract the funding and research that breast cancer does. Which is sad because this cancer is not just hidden inside the body. It's also a hidden killer. It can't be felt like breasts can be felt. And there is no easy way to detect it, like with mammogram and other imaging techniques. Often a diagnosis of pancreatic cancer -- the fourth leading cause of cancer death in Western societies -- comes with a death sentence. And more and more, breast cancer diagnoses come with promising expectations of survival.

We may not know as much as about pancreatic cancer as we do breast cancer. But there are some behaviors that may contribute to this deadly disease. So in the spirit of prevention, consider this:

• If nobody smoked, 25 percent of pancreatic cancer cases wouldn't happen.
• Alcohol consumption can increase the risk by 15 times.
• Some studies link high meat consumption and low vegetable consumption to incidences of pancreatic cancer.
• Folate, the B vitamin in green leafy vegetables, oranges, legumes, and whole grains seem to reduce the risk. But folate supplements don't seem to have the same healthy effect.

Beginning August 5 and running through to August 13, Odd Job Humanitarians are offering their services to local residents of Victoria in an effort to raise money for cancer research. During the Week to End Cancer, Oak Bay high school graduate Scott Baker is spearheading the campaign that will offer handyman and odd job services as a way to solicit monetary donations for cancer research -- instead of just asking people for money.

The Victoria News has published a nice feature about Scott Baker. He started raising money for the BC Cancer Foundation when he was in 9th grade. In his senior year, he was diagnosed with Hodgkin's Lymphoma.

Baker and fellow Odd Job Humanitarians are college students with little disposable income but lots of brawn, brains and big hearts. They state that no job is too odd or too small - and they will clean windows, dig ditches, even help sort through an attic and organize memorabilia. Sounds like a win-win proposition.

If you live in the area and would like to support cancer research and need a few odd jobs done, visit Victoria News feature story Volunteers clean for cancer to contact Scott Baker and the Odd Job Humanitarians.

Apple CEO Steve Jobs delivered a commencement speech at Stanford University on June 12, 2005. It was about following curiosity and intuition, about looking back and connecting the dots in life, about beginnings and endings, about death. Jobs, a survivor of pancreatic cancer, knows a thing or two about facing death. And the words he chose to relate his life-threatening experience to a crowd full of hopeful graduates are powerful and inspiring. I could paraphrase his message -- but surely something would be lost in my translation. So here is a bit of what he said -- word for word.

Dealing with cancer in private is hard. Dealing with cancer publicly can be even harder. CEO Donna McAleer -- the founding executive and public face of the large, growing health care company Elant -- knows this firsthand. She just recently went public with her breast cancer diagnosis and prognosis after rumors of her demise started circulating. McAleer set the record straight, announcing that she is doing just fine. While her experience has been frightening, she is surviving well -- and she wants the public to know. She has run Elant for 20 years and wants to dispel any myths about its stability. Apple CEO Steve Jobs faced the same public drama in 2004 after surgery for pancreatic cancer and subsequent drops in Apple stock. Jobs recovered -- and so did the stock -- but the speculation that swirled was powerful and potentially damaging. Just as it was that same year when Kraft Foods was criticized for withholding details of its CEO's hospitalization.

There is some debate in the business world about all of this -- about whether or not executive illnesses should be disclosed. For public companies, one opinion is that there is an obligation to respond quickly to the public. In a private company, it's up to the CEO. McAleer's Elant is not a publicly traded company and there is no worry about stock price -- but her decision to reveal her personal health crisis was the right thing to do, she says. "I have an obligation to share this news in how I progress, in order to educate and make sure people aren't frightened by it," she said in reference to the memo she sent to her 700 employees and community groups too.

I'm open and honest about my own cancer experience because I believe it can help others -- and it helps me to talk about it too. So I'm a fan of a forthcoming approach in the workplace. I appreciate that some fear repercussions that might result from such a disclosure. But honesty may be the best policy -- for prevention of rumors and addressing worry and raising awareness too. McAleer seems to agree as she takes this opportunity to speak up, to encourage women to seek mammograms and to follow up on them.

When I first started going to counseling, I was told I would need eight to 10 sessions of cognitive behavioral therapy to help me deal with my anxiety, my panic, my fear of breast cancer recurrence. My first session was in May 2005 -- and I am still going. Those initial sessions are possibly all I really needed -- and perhaps I could have stopped the therapy long ago. But stopping never came up and no one told me I had to call it quits so I kept on marching into territory I had never before traveled. I have a degree in counseling -- but I'd never been counseled. I know how to listen to others and share empathy and ask open-ended questions -- but I'd never been the one talking and sharing and venting and crying and answering questions. Until last May -- when I discovered the appeal and the comfort of the counseling chair.

I marched into one of my sessions yesterday and plopped into a brown faux leather recliner. I talked about my recent graduation from Herceptin therapy and about how I might manage in life now that treatment is over. I talked about my jobs -- as a writer and a preschool teacher -- and how they fit into my world. I talked about the level of stress in my days and about how my once constant fear that cancer was trailing me has largely diminished. I talked about how breast cancer is no longer my constant companion -- about how it is now just an acquaintance. And I talked about how counseling was once so necessary and about how it is now just a luxury that helps me maintain peace as I live forward.

I am not sure when I will stop going to counseling. But I'm not completely sure of much anymore. And I've learned from counseling to not really question the future -- to just live in the moment and to give thought primarily to the here and now. And right here, right now, I'm sticking with my sessions, my one hour every month, my comforting counseling chair.

Some employers are understanding while others are not so accommodating when it comes to an employee's need for a more flexible schedule or time off from work while they undergo the rigors of chemotherapy, surgeries and other cancer treatments. According to the Disability Rights Legal Center at Loyola Law School, cancer can be considered a disability, and cancer patients treated unfairly have remedies through laws that protect the disabled.

"In fact, people with cancer face a lot of employment discrimination," states Eve Hill of the Disability Rights Legal Center. Barbara Schwerin, who heads the Cancer Legal Resource Center, estimates they get about 300 calls from cancer patients each month. Because of the extreme fatigue, and other disabling side effects a cancer patient can suffer from cancer surgeries and treatments, patients often worry if they will lose their job in the process. Schwerin reassures them that they often have legal rights that will protect them from less understanding employers. Really, the last thing a cancer patient needs to worry about -- while they are fighting to stay alive and survive cancer -- is whether they will have a job or a roof over their heads and food in the pantry.